Summary.-A variant subline (B16-F10-B2) selected from the B16-F1O melanoma cell line, shows greater metastatic capacity and preferential growth in the brain after i.v. injection into C57BL/6 mice. Several biological properties of these two cell lines have been compared, in an an effort to determine the mechanisms responsible for this non-random metastatic pattern. No differences in cell morphology, in vitro growth rates or exposed cell-surface proteins were detected. Quantitative analysis of tumour-cell arrest and distribution using 125IUdR-labelled cells indicated that, although initial arrest patterns of the cell lines were very similar, B16-F10-B2 cells survived in the lungs to a greater extent than B16-FlO cells. Karyotype analysis revealed that the B16-F10-B2 cell line had a higher mean number of chromosomes than the parent line, whereas the variance of chromosome distribution was less. We suggest that the selection of a brain-colonizing variant represents the emergence of a pre-existing subpopulation of cells, and provides a useful model for studying mechanisms of intracranial metastasis.
INTRACRANIAL METASTASES are a frequent complication of systemic cancer. It has been reported that 16-5% of patients with generalized neoplastic disease have intracranial metastases at necropsy (Aronson et al., 1964) . Of patients afflicted with tumours such as malignant melanoma, the percentage affected by secondary brain tumours can be as high as 50-60% (Aronson et al., 1964; Posner & Shapiro, 1975; Posner, 1974; Patel et al., 1 978) . The effect of tumour development in the central nervous system (CNS) can be particularly devastating, since most patients develop major neurological symptoms that are both physically and psychologically debilitating (Posner & Shapiro, 1975) . Survival after the development of cerebral metastases is rare, and treatment is generally unsuccessful in spite of increasingly aggressive therapeutic interventions (Posner, 1974; Posner & Shapiro, 1975) .
The difficulty in developing effective therapeutic modalities for intracranial metastases is in part due to a lack of suitable experimental models of metastatic brain tumours (Conley, 1979) . In determining therapeutic regimens, the value of results from experimental animal systems depends on the use of a biologically appropriate model (Fidler, 1978) . There would appear then to be a need for a suitable model for intracranial metastasis.
The induction of rodent brain tumours by direct intracranial inoculation of tumour cells (Conley & Remington, 1977; Ausman et al., 1970; Gershbein et al., 1975) or virus particles (Rabson et al., 1974; Roseman et al., 1978; Yung et al., 1975) circumvents the need for tumour cells to cross the blood-brain barrier, as they must do in the clinical situation. The use of intracarotid (Ushio et al., 1977) or intracardiac (Conley, 1979) injections of tumour cells has produced experimental brain metastases in rodents, but these techniques require greater dexterity and technical ability than the more simple i.v. injection.
Malignant melanoma in man disseminates predominantly to both the lungs and the brain (Patel et al., 1978) . A brainseeking variant line has been isolated from a murine B 16 melanoma, but its propensity for the CNS appeared to be at the expense of its lung-colonizing ability (Brunson et al, 1978) . In our laboratory we are investigating certain aspects of the biology of metastasis, using the BI 6 melanoma syngeneic to C57BL/6 mice, which does not growr routinely in the brains of mice after i.v. inoculation. During a recent study we observed that, if Bl 6-F1 0 melanoma cells were treated with cytoskeleton-disrupting druigs before injecting them into mice, altered metastatic patterns were produced . In the present study we report how we have used this fact to select for a highly malignant variant of the B16 melanoma that will produce both lung and brain tumours in mice after i.v. injection of tumour-cell suspi nsions. This cell line very closely iniiniics the behaviour of human tumours, an1,11d s,hould serve as a uiseful animal model for the study of brain metastasis.
MATERIALS AND METHODS
Mico.-Male C57BL/6 mice aged 6-8 X-eeks wrere obtained from the Animal Production Area of the Frederick Cancer Research Ceniter.
Cell lines.-The original tumour line was the B16-F10 melanoma, syngeneic to the C57BL/6 mouse, selected by Fidler (1973) for its considerable ability to colonize to the lung. Tumour cells were grow n in Falcon tissue-culture flasks writh Eagle's minimum essential medium (EMEM) as described previously (Fidler, 1974 Three representative inocula from eaclh cell suspension were placed into vials and monitored for radioactivity in a well-type Nal crystal scintillation counter to determine activity per cell. At 10, 60, 120 min and 1 day after i.v. injection, 5 mice from each group were killed. Lungs, liver, spleen and 0-2 ml of blood were collected from each animal. The head was amputated and the lower jaw removed to elimninate the thyroid; the cranium -was then treated in the same way as other organs. The organs were placed in 7000 ethanol, which was replaced twice in the next 2 days to remove ethanol-soluble 1251. The residual ethanol-insoluble radioactivity was considered to be associated writh tumour cells viable at the time of organ removal (Fidler, 1970) .
Karyotype. Karyotypes of the parent B16-F1O and the selected brain-colonizing lines -were prepared by conventional techniques. The cells were accumulated in metaphase by the addition of 1 ,ug/ml colcemid for 3 h at 37°C. The cells were theii harvested from the substrate with 02%o trypsin and washed in phosphate-buffered saline (PBS). The cell pellet was resuspended in 5 ml 0-075M KCI for 30 min at room temperature (23°C) and the cells then fixed by the addition of an equal volume of fresh fixative (3:1 methanol: acetic acid). Fixed cells wNere dropped on to ice-cold wet microscope slides, dried on a warm plate and stained with Giemnsa solution.
In vitro growth curves. Labelling of cell-surface proteins.-Tumour cell-surface membrane proteins were radioiodinated using a lactoperoxidase-catalysed iodination technique of Marchalonis et al. (1971) . The cell-surface radiolabelled proteins were resolved by separation using sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970) .
RESULTS

Selection of a brain-colonizing variant
The treatment of B16-F1O tumour cells with CB plus colchicine before their i.v. injection into mice, led to the formation of intracranial metastases. Cells recovered from the cerebral lesions and cultured in vitro were designated B16-F1O-Bl. Injection of 5 x 104 viable cells of this line into mice by the intracardiac or i.v. route resulted in 1/10 and 5/10 mice, respectively, developing grossly obvious melanoma colonies in the cerebrum by 3 weeks after injection. The tumour line B16-Fl 0-B2 was developed from a lesion isolated from a single mouse afflicted with a brain tumour after intracardiac injection. After isolation, the cell line was allowed to grow in vitro until sufficient numbers were available, when they were frozen and stored in liquid N2. All comparisons between the cell lines were then based on samples taken from these frozen stocks at the same time. The results from 3 separate experiments examining the in vivo behaviour of the cell lines are presented in Table I Cells preincubated with cytochalasin B and colchicine were maintained in tissue culture for 2 weeks. They were then harvested and injected into 10 female and 10 male mice as detailed above. None of the mice so treated developed any visible brain tumours by 3 weeks after injection. There were no differences between the number of lung nodules after injection of these cells and of an equal number of BI6-FFO cells into 20 control animals.
In those mice developing brain tumours, the gross lesions were obvious as small, discrete black areas, generally 2-3 per mouse, diffusely scattered throughout the dorsal cerebrum (Fig. 1) . Histological examination revealed that these black areas were composed of small foci of melanoma cells, located predominantly on the surface of the cerebral hemispheres; small foci of tumour cells were found within the white matter (Fig. 2 ) but metastases were not seen in either the ventricles or the choroid plexus. It appeared that initially the cells were arrested and grew in the meningeal blood vessels, and later expanded and infiltrated into the brain parenchyma (Fig. 2) were a mixture of black and pearl-grey colonies, and many of the nodules were composed of a central dark core surrounded by an opalescent grey circle (Fig. 3) . Three weeks after they were inoculated with B16-F1O-B2 cells, mice generally displayed no neurological signs. However, when one group of 9 mice was allowed to live over 3 weeks, they showed a high incidence (7/9) of neurological disorders associated with the formation of brain tumours by 4 weeks after injection. These neurological signs were blindness, hindleg paralysis, ataxia and staggering, circling and incoordination.
Stability of brain-colonizing variant
The B16-F1O-B2 cell line maintained its brain-colonizing property after 4 months of continuous tissue culture or 2 s.c. passages in mice over a 2-month period, Table II . Tumour cells of the B16-FIO-B2 line survived in the lungs to a greater extent than B16-F10 cells (32°, vs 11% viable at 1 day) in spite of initial arrest being very similar. Very few tumour cells localized in the cranium (maximum of 10 by 2 h) but there appeared to be no obvious difference between the survival of B16-FIO and BI 6-F I0-B2 cells at this site. There might have been a trend for B16-F1O-B2 cells to survive better than B16-Fl0 cells in the cranium but, owing to the small numbers of cells involved and the difficulty in evaluating them, the difference was not significant. The clearance of B16-FIO and B16-F10-B2 from the lungs after i.v. injection is shown in Fig. 4 . The clearance of cells from the lungs is biphasic, with initial rapid clearance followed by a period of slower removal. It is of interest that the rate of B16-FIO-B2 clearance is slower than that of B16-F1O cells in both phases of the curve.
Karyotype analysis
The number and distribution of chromosomes and the mean chromosome numbers in the cells from the B16-FlO, B16-F1O-Bl and B16-F1O-B2 melanoma cell lines are represented in Fig. 5 . The values were based on 100 counts on each cell line. The mean numbers of chromosomes were 68-9, 73-4 and 80-7 for B16-FIO, B16-F10-BI and B16-Fl0-B2, respectively, and the means of B16-F1O-B2 and B1]6-FI0 were significantly different (P < 0 00l Student's t test). Moreover, the variance of chromosome distribution became smaller with increasing selection (B16-FIO 386K1, B16-F10-B1 345 7, B16-FlO-B2 301-8).
In vitro growth curves No differences were seen among the 3 cell lines (B1 6-F1O, B16-F1O-B1 and B16-F1O-B2) in their in vitro growth rates. All 3 lines had population-doubling times of H-12h (Fig.6 ).
Cell morphology
Representative interference photomicrograplhs (Nomarski) are shown in Fig. 7 (Rabson et al., 1974; Ausman et al., 1970; Gershbein et al., 1975; Yung et al., 1975; Conley & Remington, 1977; Roseman et at., 1978) . Also, intracardiac or intracarotid injections of tumour cells (Ushio et al., 1977; Conley, 1979 ) require greater technical expertise than i.v. inoculation. In order to initiate the selection procedure and obtain brain tumours, the first B 1 6 cells to be passaged were treated with a combination of cytochalasin B and colchicine at a level which had previously been shown to increase extrapulmonary metastasis from tumour-cell injection (Nowell, 1976 (Fidler & Kripke, 1977) and an increasing body of evidence suggests that many other tumours are also heterogeneous in metastatic capacity (for review see Fidler et al., 1978; . The isolation of different variant lines from the same parental tumour allows one to compare the properties likely to be important for metastatic spread without referring to "normal cells", a comparison of doubtful validity. Tumour cell lines with preferential organ colonization have been isolated previously from the B 16 melanoma (Brunson & Nicolson, 1979; Fidler, 1973; Tao et al., 1979) including a line which preferentially seeks brain tissue but not lung tissue (Brunson et al., 1978) . It would seem that the lines established by us and by Brunson et al. (1978) are markedly dissimilar in both biological and cell-surface properties, which may make the lines suitable for different investigations. Differences in properties are hardly surprising, since it has been shown, by different isolation techniques, that variants isolated from the same parental population for the same phenotype vary considerably in many respects (Poste et al., 1980) . It should be emphasized that, in contrast to Brunson et al. (1978) we have not isolated a specifically brain-localizing tumour-cell variant. Rather, the line we have isolated is generally more metastatic with an increased capacity for colonizing both lungs and brain. It is of interest that although the B16-F]0--B2 line produced an increased incidence of extrapulmonary metastases, this increase was not of the same magnitude as the increase in the incidence of brain tumours. In our model, then, a preferential localization of metastatic deposits in brain tissue is similar to that seen in cases of disseminated malignant melanoma in man (Aronson et al., 1964; Patel et al., 1978) . Investigations are currently in progress in our laboratory to attempt to determine those tumour and host properties that allow these cells to grow in the CNS.
